Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system)
NICE guidance
Summary (source: NICE)
Reference: HTG353
Type: NICE guidance
Published: 24 September 2014
Last updated: 19 December 2017
Issued by: National Institute for Health and Care Excellence (NICE)
Full guidance: Read on nice.org.uk →
Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) is nice guidance HTG353, issued by the National Institute for Health and Care Excellence (NICE), which produces evidence-based recommendations for health and care in England.
Note: NICE guidance is published under a licence that applies to the UK and does not permit republication of the full text. This page provides the reference and a direct link to the official document. Read the full guidance on nice.org.uk →
Document official
Official summary published by the National Institute for Health and Care Excellence (nice.org.uk), last published 24 September 2014. Indicative information for healthcare professionals — refer to the full document. Reference and link only, per NICE licence.